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SUMMARY
The obesity epidemic is a significant global health
issue. Improved understanding of the mechanisms
that regulate appetite and body weight will provide
the rationale for the design of anti-obesity therapies.
Thyroid hormones play a key role in metabolic
homeostasis through their interaction with thyroid
hormone receptors (TRs), which function as ligand-
inducible transcription factors. The TR-beta isoform
(TRb) is expressed in the ventromedial hypothalamus
(VMH), a brain area important for control of energy
homeostasis. Here, we report that selective knock-
down of TRb in the VMH of adult mice results in se-
vere obesity due to hyperphagia and reduced energy
expenditure. The observed increase in body weight
is of a similar magnitude to murine models of the
most extreme forms of monogenic obesity. These
data identify TRb in the VMH as amajor physiological
regulator of food intake and energy homeostasis.
INTRODUCTION
Energy homeostasis is regulated by neurotransmitters and by
humoral factors including thyroid hormones, which act within
the hypothalamus and systemically to regulate food intake
(Coppola et al., 2007; Coll et al., 2007) and energy expenditure
(Kim, 2008). The effects of the active form of thyroid hormone,
3,5,30-L-triiodothyronine (T3), are mediated by two thyroid
hormone receptors (TRa and TRb), encoded by Thra and Thrb,
respectively (Brent, 2012).
Metabolic phenotypes have been described in mice and hu-
mans with TR mutations. Mice with heterozygous dominant-
negative mutations of TRa display a variety of metabolic pheno-
types ranging from hypermetabolism, hyperphagia, and resis-
tance to diet-induced obesity (Sjo¨gren et al., 2007) to increased
visceral adiposity, hypophagia, and impaired cold-induced
adaptive thermogenesis (Liu et al., 2003). The variation in
described phenotypes is likely to be due to the differing actions
of individual mutant receptors on wild-type TR function (Ortiga-
Carvalho et al., 2014). Humans with heterozygous dominant-
negative mutations of TRa (resistance to thyroid hormone
a [RTHa]) may be overweight or obese with reduced energy
expenditure (Bochukova et al., 2012; Moran et al., 2013, 2014).
Humans with heterozygous dominant-negative mutations of
TRb have RTHb, resulting in high levels of circulating thyroid hor-
mones and thyroid-stimulating hormone (TSH) due to impaired
negative feedback of the hypothalamic-pituitary-thyroid axis
(Ortiga-Carvalho et al., 2014). Humans with RTHb may be over-
weight and hyperphagic (Mitchell et al., 2010) despite features of
hyperthyroidism such as tachycardia and raised energy expen-
diture due to T3 actions in TRa-responsive tissues. These exten-
sive studies demonstrate that thyroid hormone is an essential
regulator of food intake and energy expenditure. Despite this,
clinical and global gene targeting studies cannot differentiate be-
tween the developmental and adult, or systemic and central, ef-
fects of thyroid hormones.
The ventromedial hypothalamus (VMH) is a critical region of
the brain involved in energy homeostasis. TRb is the predom-
inant TR isoform expressed in the VMH (Cook et al., 1992;
Barrett et al., 2007), and previous studies suggest that thyroid
hormones acting in the VMH regulate both food intake (Kong
et al., 2004) and energy expenditure (Lo´pez et al., 2010). Thus,
we hypothesize that, in the VMH, TRb physiologically regu-
lates food intake and body weight. To investigate this hypoth-
esis directly, we used stereotaxic Cre-lox gene targeting to
generate a VMH-specific model of TRb knockdown in adult
mice.
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RESULTS
Tissue-Specific Knockdown of TRb in the VMH in Adult
Mice
We knocked down TRb in the VMH of adult male mice using
Cre-mediated excision of a floxed critical exon in the Thrb
gene. This approach enabled temporally and spatially controlled
reduction of TRb expression specifically in the VMH of adult
mice. This model eliminates the developmental consequences
and abnormal systemic thyroid hormone levels that occur in
global TRb mutant mice (Ortiga-Carvalho et al., 2014) or in hy-
pothyroid and thyrotoxic animals (Ishii et al., 2003; Lo´pez
et al., 2010).
The Thrbflox allele contains loxP sites flanking exon 5 of Thrb
(Winter et al., 2009) (Figure S1A). Cre-recombinase-mediated
excision of this critical exon results in inactivation of Thrb (Winter
et al., 2009). Cre recombinase was introduced into the VMH of
adult male Thrbflox/flox mice by stereotaxic injection of recombi-
nant adeno-associated virus (rAAV) expressing a Cre-GFP fusion
protein to generate mice with reduced TRb expression in the
VMH (VMH-TRb) mice. Thrbflox/flox mice injected with rAAV en-
coding GFP into the VMH (VMH-GFP) were used as controls.
Cre-mediated excision of the Thrbflox allele was confirmed by
PCR of DNA from whole hypothalami of VMH-TRb mice
(Figure S1B). The Thrbflox allele was not excised in either the
cerebellum or brainstem, indicating rAAV did not enter the ven-
tricular system following stereotaxic injection (Figure S1B). Fluo-
rescence microscopy and in situ hybridization (ISH) both
confirmed transgene expression localized to the VMH in both
groups of mice (Figures S2A and S2B). ISH using a probe spe-
cific for the floxed exon of Thrb demonstrated reduced expres-
sion within the VMH of VMH-TRbmice compared with controls
(Figures S2C and S2D).
Selective Knockdown of TRb in the VMH in Adult Mice
Results in Hyperphagia and Obesity
VMH-TRb mice consumed more food and gained more weight




Figure 1. Effect of Reduced TRb Expression in the VMH
(A) Cumulative food intake.
(B) Cumulative body weight change.
(C) Body weight on day 42.
(D) Photograph of VMH-GFP and VMH-TRb mouse.
(E) Hypothalamic expression of Pomc.
(F) Hypothalamic expression of Npy.
In (A)–(C), the results aremean ±SEM; n = 10 for VMH-GFP and 11 for VMH-TRb. In (E) and (F), the results aremedian, andwhiskers areminimum andmaximum;
n = 3 for VMH-GFP and 4 for VMH-TRb; *p < 0.05; **p < 0.01. Food intake and body weight were analyzed using a generalized estimating equation exchangeable
correlation matrix and robust SEs (GEE), body weight data t test. See also Figures S1–S3 and Tables S1 and S2.
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mice was three times greater than that of control mice by the end
of the study (Figures 1C and 1D).
Whole hypothalami for RNA-sequencing (RNA-seq) analysis
were collected from mice before significant changes in body
weight had occurred. This was so that changes in expression
are likely to be due to changes in thyroid hormone signaling
rather than secondary effects of the increase in body weight
and food intake. Differential expression analysis was performed
(Table S1). Pathway analysis of differentially expressed genes re-
vealed an over-representation of genes involved in dopamine,
growth hormone, and leptin signaling pathways, as well as
genes that are involved in neuronal activity regulation including
long-term potentiation (LTP) and long-term depression (LTD);
these results were qualitatively the same when the false
discovery rate (FDR) for analysis was set between 0.001 and
0.1 (Table S2). Among the genes differentially expressed,
Pomc expression was decreased (log Fc 1.38, p = 9.33 3
107) (Figure 1E), whereas Npy expression was increased
(log Fc 0.7, p = 9.42 3 106) (Figure 1F), whereas that of Thrb
was not altered at the level of the whole hypothalamus (Table
S1). Expression of steroidogenic factor 1 (Nr5a1), and uncou-
pling protein-2 (Ucp2), both of which are implicated in hypo-
thalamic control of energy homeostasis (Majdic et al., 2002;
Coppola et al., 2007), were unchanged. The differentially ex-
pressed genes were compared to those previously reported to
be T3 responsive or directly regulated by T3 in cerebrocortical
cells (Tables S1 and S2 and Figure S3) (Gil-Iban˜ez et al., 2017).
Of the genes directly regulated by T3 in cerebrocortical cells,
we identified 89 (15%) were also significantly changed in our
samples, among which was hairless (Hr). For genes regulated
indirectly by T3, we identified 133 that were also changed (9%).
Total, visceral, subcutaneous, and epididymal fat mass were
all increased in VMH-TRb mice compared to controls (Figures
2A–2E). In keeping with the increased adiposity, VMH-TRb





Figure 2. White Adipose Tissue Mass and Distribution
MRI quantification of fat demonstrated that VMH-TRb mice had significantly higher fat mass.
(A) Representative transverse T1-weighted MR images through the abdominal region of a VMH-GFP and VMH-TRb mouse.
(B) Total body fat.
(C) Visceral fat.
(D) Subcutaneous fat.
(E) Epididymal fat pad weight on day 42 (n = 10).
(F) Plasma leptin levels on day 42 (n = 10).
Results are mean ± SEM (n = 3 per group unless stated). **p < 0.01 versus control, t test with Bonferroni correction. See also Figure S4.
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VMH-TRb Mice Are Systemically Euthyroid
Alterations in circulating thyroid hormones affect food intake and
body weight (Pijl et al., 2001). Measurement of plasma TSH,
thyroxine (T4), and T3 confirmed that both VMH-TRb and con-
trol mice were euthyroid (Figures S4A–S4C).
VMH-TRb Mice Are Insulin Resistant but Do Not Show
Changes in the Expression of Genes Involved in
Hypothalamic Glucose Sensing
Obese VMH-TRb mice had high levels of fasting insulin (Fig-
ure S4D), as expected. However, when glucose tolerance and in-
sulin tolerance were tested before the development of obesity in
the VMH-TRb mice, there were no differences between the
VMH-TRb and VMH-GFP mice (Figures S4E and S4F). RNA-
seq analysis did not identify changes in expression of hypotha-
lamic glucose-sensing genes.
Obesity in VMH-TRbMice IsNotDue to TRbKnockdown
in Other Brain Areas
To confirm that the observed weight gain and hyperphagia in
VMH-TRb mice resulted from reduced TRb expression in the
VMH and not spread through the ventricular system into other
brain regions, rAAV-Cre was injected into both lateral ventricles
of Thrbflox/flox mice; a control group of mice were injected with
rAAV-GFP. There was no difference in cumulative food intake
or body weight gain between these two groups (Figures S4G
and S4H).
VMH-TRb Mice Fail to Mount an Orexigenic Response
to Administered T3
In order to validate loss of T3 signaling following TRb inactivation
in the VMH, we administered T3 to VMH-TRb and VMH-GFP
mice by subcutaneous injection. Over the 24-hr study period,
T3 significantly increased food intake in VMH-GFP mice but
VMH-TRb mice failed to mount an orexigenic response to the
administered T3 (Figure S4I).
VMH-TRb Mice Do Not Become Obese When Pair-Fed
to the Food Intake of Lean Controls
To investigate whether the hyperphagia contributed to, or was a
consequence of, the development of the obese phenotype,
VMH-TRb mice were pair-fed to the food intake of a weight-
matched VMH-GFP littermate for 5 weeks. During pair-feeding,
there was no difference in cumulative body weight change or
food intake (Figures 3A and 3B) or locomotor activity between
the two groups.
After 5 weeks of pair-feeding, ad libitum access to food was
restored for 4 weeks. Following restoration of free feeding,
VMH-TRb mice gained significantly more weight and
consumed significantly more food than controls (Figures 3A
and 3C).
VMH-TRbMice Have Reduced Energy Expenditure and
Reduced Locomotor Activity
The contribution of changes in energy expenditure to the obese
phenotype was investigated. Oxygen consumption (VO2), carbon
dioxide production (VCO2), and locomotor activity were all
decreased during the dark phase in ad libitum-fed VMH-TRb
mice both before and after the onset of obesity (Figures 4A–4C).
By contrast, there was no difference in VO2, VCO2, or locomotor
activity during the light phase (Figures 4A–4C). The decrease in
nocturnal locomotion in VMH-TRb mice was confirmed by
behavioral analysis (Table S3). There was no difference in respira-
tory exchange ratio (RER) (Figure 4D) and no difference in brown
adipose tissue (BAT) uncoupling protein-1 (Ucp1) expression (Fig-
ure 4E) between VMH-TRb and control mice. In addition, VMH-
TRb mice have a normal body temperature (Figure S4J).
DISCUSSION
These studies identify hypothalamic TRb as an important physi-
ological regulator of appetite and body weight. Reduced TRb
expression in the VMH resulted in marked weight gain,
B CA
Figure 3. Effect of Pair-Feeding on VMH-TRb Mice
(A) Weight gain over the entire period of the experiment. During weeks 0–5, food intake of each VMH-TRb mouse was limited to that of a weight-matched,
VMH-GFP littermate. From weeks 5 to 9, ad libitum access to food was restored.
(B) Food intake during the pair-feeding period.
(C) Food intake during the ad libitum feeding period.
Results are mean ± SEM. n = 9; GEE, *p < 0.05; ***p < 0.001.
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comparable to severe forms of monogenic obesity (Tecott et al.,
1995; Yaswen et al., 1999). The weight gain was a consequence
of increased total body fat, and in particular a marked increase in
subcutaneous and visceral white adipose tissue, the latter being
an important risk factor for cardiovascular disease and diabetes
(Montague and O’Rahilly, 2000).
VMH-TRb mice ate more than control animals, and pair-
feeding studies indicated that hyperphagia contributed directly
to the obesity. Thus, VMH-TRb mice remained lean when
food intake was restricted but rapidly became obese when ad li-
bitum feeding was restored.
Selective TRb knockdown specifically in the VMH was
confirmed by ISH and fluorescence microscopy. Although
expression of Thrb was not reduced in the RNA-seq analysis,
these samples are derived from whole hypothalami, and there-
fore the decrease in the level in the VMH is likely masked by
the expression of Thrb throughout the rest of the sample. Indeed,
the loss of TRb function in the VMHwas demonstrated by the fail-
ure of the expected orexigenic response to administered T3 in
VMH-TRb mice and further supported by the appropriate
changes in genes directly regulated by T3. The possibility of
the phenotype arising through virus spread to other CNS areas
was excluded by rAAV-Cre injection into the lateral ventricles,
which did not result in hyperphagia or obesity.
Previous work in rats has reported the acute orexigenic effect
of exogenously administered T3 (Kong et al., 2004). Here, we
show the endogenous effect of thyroid hormone action following
selective TRb knockdown. We suggest that our current work
describes a local circuit within the VMH that physiologically reg-
ulates food intake as distinct from the feeding response to
administered pharmacological doses of T3 analogous to the
contrasting effects of NPY and PYY.
To investigate the underlying cause of hyperphagia in
VMH-TRb mice, hypothalamic gene expression patterns were
determined by RNA-seq. The expression of Pomc and Fto
were downregulated in the hypothalamus, whereas Npywas up-
regulated. POMC and FTO are thought to inhibit food intake,
whereas NPY simulates food intake; therefore, these changes
in expression may explain in part the phenotype observed.
Energy expenditure in VMH-TRb mice was reduced both
before and after the onset of obesity. There was no difference
in BAT Ucp1 expression between VMH-TRb and control
mice, suggesting that adaptive thermogenesis was unaffected.
It is likely that changes in energy expenditure in VMH-TRb
mice resulted from decreased locomotor activity. The reduced
locomotor activity is not a consequence of the obesity because
it occurred before differences in body weight. In addition, during




Figure 4. Energy Expenditure and Locomotor Activity in Mice with Reduced Expression of TRb in the VMH
(A) Oxygen consumption.
(B) Carbon dioxide production.
(C) Locomotor activity.
(D) RER.
(E) Ucp1 expression in BAT (n = 7 VMH-GFP and 11 VMH-TRb).
L, light phase; D, dark phase; 1, 1 week, and 6, 6 weeks, after recovery. Data aremean ±SEM (n = 5 VMH-GFP; n = 6 VMH-TRb); ANOVAwith Student-Newman-
Keuls analysis, **p < 0.01. See also Table S3.
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possibly due to food-seeking behavior. This is likely to explain
why body weight gain did not differ between the two groups
before the restoration of ad libitum feeding. The energy expendi-
ture and pair-feeding data indicate that both increased food
intake and reduced locomotor activity contribute to obesity in
VMH-TRb mice.
In contrast to VMH-TRb mice, global heterozygous
TRb-knockout mice do not have an obese phenotype (Ortiga-
Carvalho et al., 2014). This may be explained by the peripheral
hyperthyroidism of these mice. In addition, the appetite circuits
within the hypothalamus are subject to developmental plasticity
and compensatory redundancy (Bouret et al., 2004; Horvath,
2005). For example, neither global deletion of Agrp and/or Npy
nor ablation of arcuate AgRP/NPY neurons in neonatal mice re-
sults in a metabolic phenotype (Erickson et al., 1996; Qian et al.,
2002; Luquet et al., 2005), whereas ablation of these neurons in
adult mice produces profound hypophagia and starvation (Lu-
quet et al., 2005; Gardiner et al., 2005; Bewick et al., 2005).
Similar developmental compensation may occur in global
TRb-knockout mice.
Studies using adenovirus-mediated expression of a dominant-
negative TR (DN-TR) in the rat VMH have been reported (Lo´pez
et al., 2010). Although VMH DN-TR expression did not affect
food intake or body weight in euthyroid animals, it prevented
weight loss in thyrotoxic ratsand resulted in reducedhypothalamic
AMP-activated protein kinase (AMPK) expression (Lo´pez et al.,
2010). AMPK expression was unchanged in our model. DN-TR in-
terfereswith the actions of both TRa and TRb and exerts amarked
repressive effect on gene transcription (Ortiga-Carvalho et al.,
2014; Ferrara et al., 2012). By contrast, VMH-TRb mice have
only reduced TRb activity rather than the pathological repression
of TR target genes that is present in animals expressing a domi-
nant-negative receptor. This fundamental difference is likely to
explain thecontrasting phenotypesobserved in these twomodels.
In summary, we have shown that hypothalamic TRb is an
important physiological regulator of energy homeostasis
because TRb knockdown in the VMH results in a phenotype of
hyperphagia and severe obesity that is comparable to some of
the most extreme forms of monogenic obesity (Tecott et al.,
1995; Yaswen et al., 1999). Our findings provide insights into
the central regulation of energy homeostasis by TRb that could
be a target for anti-obesity therapies.
EXPERIMENTAL PROCEDURES
Animals
Thrbflox/flox mice (Winter et al., 2009) were genotyped by PCR using specific
oligonucleotide primers (Figure S1). Mice were housed in single cages and
maintained under a controlled environment (temperature, 21–23C; 12-h
light–dark cycle, lights on at 07:00) with ad libitum access to chow and water
(RM1; SDSDiets), except where stated.Malemice that were 8weeks old at the
start of procedures were used in all experiments. All animal studies were
approved under the Animals (Scientific Procedures) Act (1986) (Project Li-
cense Number 70_7229) and approved by the Animal Welfare and Ethical Re-
view Body, Imperial College London, which is signed up to the ARRIVE (Animal
Research: Reporting of In Vivo Experiments) guidelines.
rAAV Preparation
rAAV was produced (Grimm et al., 1998) and isolated (Zolotukhin et al., 1999),
as previously described.
Confirmation of rAAV Transgene Expression, Thrb Excision, and
Reduced TRb Expression in the VMH
Excision of the Thrbflox allele within the hypothalamus was confirmed by PCR
(Figure S1). ISH using a probe specific to the excised portion of TRb was per-
formed to confirm reduced TRb expression within the VMH (Smith et al., 2008).
Measurement of Energy Expenditure
Metabolic parameters were measured by indirect calorimetry using an open-
circuit Oxymax system of the Comprehensive Lab Animal Monitoring System
(Columbus Instruments) (Gardiner et al., 2010).
RNA-Seq Analysis
RNA-seq analysis was performed using hypothalamic RNA from VMH-GFP
(n = 3) and VMH-TRb (n = 4) mice using next-generation sequencing (NGS)
technologies (Imperial BRC Genomics Laboratory, Imperial College London).
For further details, see Supplemental Experimental Procedures.
Statistical Analyses
Cumulative food intake and body weight data were analyzed using generalized
estimating equations with exchangeable correlation matrix and robust SEs.
Differences between two groups at individual time points were analyzed by un-
paired t tests; for multiple comparisons, a Bonferroni correction was applied.
Values from the behavioral study were analyzed using a one-way ANOVA fol-
lowed by Kruskal-Wallis test. Data from the energy expenditure test were
analyzed using a one-way ANOVA followed by a Newman-Keuls test. Plasma
thyroid hormones were compared usingMann-Whitney U test. Differences be-
tween groups were considered statistically significant at the 95% confidence
level (p < 0.05).
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